Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-06-024759
Filing Date
2006-04-20
Accepted
2006-04-20 06:03:23
Documents
1
Period of Report
2006-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 20831
  Complete submission text file 0001209191-06-024759.txt   22651
Mailing Address
Business Address 21720-23RD DRIVE SE, SUITE 100 BOTHELL WA 98021 4256083000
NORTHWEST BIOTHERAPEUTICS INC (Issuer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7600 WISCONSIN AVENUE SUITE 700 BETHESDA MD 20814
Business Address 7600 WISCONSIN AVENUE SUITE 700 BETHESDA MD 20814 (240) 497-4060
Toucan Partners, LLC (Reporting) CIK: 0001344441 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-33393 | Film No.: 06768545